Germany Suspends Takeda Diabetes Drug Actos
German health regulators on Friday advised doctors to halt new prescriptions of Takeda Pharmaceutical Co. Ltd.'s diabetes drug Actos in light of study results suggesting the medication could heighten the risk...To view the full article, register now.
Already a subscriber? Click here to view full article